Peptomer Aluminum Oxide Nanoparticle Conjugates as Systemic and Mucosal Vaccine Candidates: Synthesis and Characterization of a Conjugate Derived from the C4 Domain of HIV-1MNGp120
- 1 May 1997
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 8 (3) , 424-433
- https://doi.org/10.1021/bc970036p
Abstract
Peptomers are polymers composed of peptides that are specifically cross-linked in a head-to-tail fashion. Recently, a peptomer composed of an amphipathic peptide from the C4 domain of HIV-1MN gp120 was shown to display a prominent α-helical conformation that, as an immunogen, elicited rabbit antibodies recognizing native and recombinant gp120 [Robey et al. (1995) J. Biol. Chem. 270, 23918−23921]. For the present study, we synthesized a conjugate composed of the C4 peptomer covalently linked to calcinated aluminum oxide nanoparticles. The nanoparticles were first reacted with (3-aminopropyl)triethoxysilane to provide an amine load of 15.9 mmol of R-NH2/g of solid. The amine-modified aluminum oxide nanoparticles then were reacted with N-acetylhomocysteine thiolactone at pH 10 to place a reactive thiol on the nanoparticles. A bromoacetylated C4 peptomer, modified at the ε-amines of lysine residues, then was reacted with the thiolated nanoparticles to give the peptomer covalently linked to aluminum oxide via a thioether bond. The peptomer load was determined to be 16 mg of peptomer/g of particles, a 55% theoretical yield. Particle shape and size of the peptomer-conjugated alumina were analyzed by electron microscopy and displayed a mean maximum diameter of 355 nm and a mean minimum diameter of 113 nm, well within the desired size range of 300 nm believed to be optimal for mucosal immunization purposes. Experimentally determined values of mean particle diameters, specific surface area, and specific peptomer load provided the information necessary to calculate the mean antigen load, which was determined to be 53 000 ± 42 000 peptomer epitopes per particle. Peptomer−alumina conjugates, such as that described here, could form the basis of a new class of biomaterial that combines a chemically defined organic immunogen with a nontoxic chemically defined inorganic adjuvant.Keywords
This publication has 21 references indexed in Scilit:
- Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting.The Journal of Experimental Medicine, 1996
- A Synthetic Conformational Epitope from the C4 Domain of HIV Gp120 That Binds CD4Published by Elsevier ,1996
- ANTIGEN SAMPLING ACROSS EPITHELIAL BARRIERS AND INDUCTION OF MUCOSAL IMMUNE RESPONSESAnnual Review of Immunology, 1996
- A Helical Epitope in the C4 Domain of HIV Glycoprotein 120Journal of Biological Chemistry, 1995
- Surface-Modified Diamond Nanoparticles as Antigen Delivery VehiclesBioconjugate Chemistry, 1995
- Synthesis and Use of a New Bromoacetyl-Derivatized Heterotrifunctional Amino Acid for Conjugation of Cyclic RGD-Containing Peptides Derived from Human Bone SialoproteinBioconjugate Chemistry, 1995
- Identification of T-cell epitopes without B-cell activity in the first and second conserved regions of the HIV Env proteinAIDS, 1991
- A polymer containing a repeating peptide sequence can stimulate T-cell-independent IgG antibody production in VivoCellular Immunology, 1991
- Enhancement of peptide immunogenicity by linear polymerizationEuropean Journal of Immunology, 1988
- Adsorption of Gases in Multimolecular LayersJournal of the American Chemical Society, 1938